Treatment of the infections caused by methicillin-resistant Staphylococcus aureus (MRSA) strains in orthopedic patients is a difficult and laborious process for both the patient and physician. Staphylococcus aureus(S. aureus) is one of the leading causes of community-acquired and nosocomial infections. In this study, we aimed to investigate the susceptibilityof the MRSA strainsisolated in orthopedic patients cultured for different reasons in our clinic to various antibiotics, and to evaluate clinical characteristics of the patients and factors affecting the prognosis. A total of 40 patients with MRSAisolated in our orthopedics clinic between December 2012 and November 2016 were retrospectively analyzed. Data including age, sex, comorbidities, previous surgeries, and previous antibiotic treatments were obtained from patients' files and electronic information system. Of 40 patients, 60% were male, and 56% were over 60 years old. While 80% of the patients underwent an orthopedic surgery, 20% of them received no surgical intervention before the diagnosis. A total of 90% were in-patients, and the mean length of hospital stay was 22 days. The mean time from the date of hospitalization to the isolation of MRSA was 12 days. According to the consultation findings, in the clinical recovery process of the patients and in the treatment algorithm given to those patients, vancomycin and teicoplanin were found to be among the most important treatment options, in addition to significant debridement to be done, for MRSA strains. Our study results suggestthat, in addition to the surgical debridement, timely antibiotherapy is of utmost importance to reduce mortality and morbidity in MRSA-positive orthopedic patients.
Introduction
Staphylococcus aureus (S. aureus) is one of the Gram-positive pyogenic bacteria which has aggregation features and can be found in the human skin and mucous membranes [1] . This microorganism may cause serious systemic infections such as bacteremia, endocarditis, toxic shock syndrome, and skin infections such as cellulitis, impetigo, and wound infections [2] . The major problem in the treatment of staphylococcal infections, which are one of the leading causes of community-acquired and nosocomial infections, is methicillin resistance. Methicillin-resistant S. aureus (MRSA) strains were previously isolated from nosocomial infections. However, they are seen in the community-acquired infections in recent years [3] . In several studies, S. aureus bacteremia was reported to have a mortality rate ranging from 13 to 34% [4, 5] .
In this study, we aimed to investigate the susceptibility of the MRSA strains of the MRSA strains isolated in orthopedic patients cultured for different reasons in our clinical microbiology laboratories to various antibiotics, and to evaluate clinical characteristics of the patients and factors affecting the prognosis. All patients were followed in the in-patient setting, and the mean length of hospital stay was 22 (range: 7 to 83) days. The mean time from hospitalization to the MRSA recurrence was 12 days. Treatment algorithms consisting of three steps were performed, according to the antibiotic resistance of the patient ( Table 2 ).
The patients in the orthopedics clinic underwent surgery within the last two months. The risk gradually increased in the patients with arthroplasty and open fractures, in elderly, and in those with prolonged hospitalization. All MRSA cases were considered as nosocomial infections or infectious agent associated with the health care by the relevant department. During follow-up, five patients (12.5%) died before cure was achieved. Non-survivors were elderly patients with joint arthroplasty.
Age, sex, comorbidities, previous surgeries, hospitalization within the last month, infection-related hospitalization, duration of hospitalization, and the presence of accompanying infections were found to be among the main factors affecting mortality. Of 35 patients who underwent orthopedic interventions and serial debridement, adequate response was achieved in 22 (62.8%) in their clinical follow-up (p<0.05).
Discussion
The prevalence of MRSA varies between countries and between hospitals [6] . This ratio was found to be changed between 0.1% and 34.4% in a multi-center study including European countries [7] . In Turkey, it ranges between about 9 and 40% [8] . Therefore, infections caused by multidrug-resistant bacteria, such as MRSA, complicate the treatment.
The treatment of MRSA is expensive and difficult, and it is considered a serious problem, as it can spread rapidly [9] . It may be present in hospitals endemically, which means it can be present without leading to an epidemic outbreak. However, it may result in outbreaks in some cases. To date, a great number of epidemic MRSA strains, which lead to epidemics, have been identified [10] . Expensive antibiotic treatments, intensive isolation measures, and prolonged hospitalization lead to a great financial burden on the health care settings.
In several studies, all isolated strains are recommended to be typed, when an epidemic or endemic increase is detected in the infection rates related to MRSA, and it is recommended to investigate the common source if a large clonal relationship is found between the strains in the results of typing [11] . Typing methods are important, since they are the indicators of the Infection Control Committee to prevent the nosocomial outbreaks and in the discovery of the causative agent and mode of transmission.
In previous studies, the mortality rate associated with MRSA has been reported between 10 and 40% [12, 13] . Similarly, the mortality rate in our study was 12.5%. Monitoring and treatment of MRSA infections have become to be more dwelled on, since the mortality rates in orthopedic patients are high and the incidence of the nosocomial infections increases.
The main goal of the treatment is to provide eradication of the infection, and is to make the joint painless and functional. The treatment has two components which are surgical approach and antibiotherapy. Early diagnosis increases the success of antibiotherapy as well as it reduces the invasive procedures. Recognition of the risk factors also provides rational antibiotic use in a timely manner. The surgical choice, virulence, and susceptibility of the pathogen, duration of the symptoms, implant stability, status of peripheral tissues (bone stock), and epidemiological data (place where the surgery is performed, procedure and surgical team or relapse rates of the center, factors and mortality) are determined by the experience of the surgeon [14, 15] .
In studies examining the risk factors on the mortality, rational empirical antibiotic choice and timely treatment as well as the serial debridement in orthopedic patients have been found to be significant factors in the eradication of the infection [16] . In our study, serial debridement and the removal of infected bone and tissue structures from the medium played a critical role in for the treatment. In previous studies, mortality was reported to be high in the MRSA infections of the elderly with organ failure [17, 18] . In our study, mortality was similarly found to be high in elderly.
Usual hygienic measures and prevention of transmission are the main factors in the prevention and control of MRSA. The small number of patients and the lack of control group as a limitation of this study. However, there is a nSeed for further multi-center studies which would explain the role of surgical debridement in the infected patients as well as the role of antimicrobial drug administration.
Conclusions
In conclusion, our study results suggest that, in addition to the surgical debridement, timely antibiotherapy is of utmost importance to reduce mortality and morbidity in MRSA-positive orthopedic patients. 
